Neoadjuvant therapy of sequential TACE, camrelizumab, and apatinib for single huge hepatocellular carcinoma (NEO-START): study protocol for a randomized controlled trial.
Saved in:
| Title: | Neoadjuvant therapy of sequential TACE, camrelizumab, and apatinib for single huge hepatocellular carcinoma (NEO-START): study protocol for a randomized controlled trial. |
|---|---|
| Authors: | Hao, Yun1 (AUTHOR), Xie, Fei2 (AUTHOR), Zhou, Yongjie3 (AUTHOR), Li, Chuan1 (AUTHOR), Zhang, Xiaoyun1 (AUTHOR), Shen, Junyi1 (AUTHOR), Yao, Minghong4 (AUTHOR), Sun, Xin4 (AUTHOR), Zhou, Jin1 (AUTHOR), Wen, Tianfu1 (AUTHOR), Peng, Wei1,4 (AUTHOR) pengwei@wchscu.edu.cn |
| Source: | Trials. 7/19/2024, Vol. 25 Issue 1, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 178528802 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Neoadjuvant therapy of sequential TACE, camrelizumab, and apatinib for single huge hepatocellular carcinoma (NEO-START): study protocol for a randomized controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Hao%2C+Yun%22">Hao, Yun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xie%2C+Fei%22">Xie, Fei</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Yongjie%22">Zhou, Yongjie</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Chuan%22">Li, Chuan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Xiaoyun%22">Zhang, Xiaoyun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shen%2C+Junyi%22">Shen, Junyi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yao%2C+Minghong%22">Yao, Minghong</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun%2C+Xin%22">Sun, Xin</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Jin%22">Zhou, Jin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wen%2C+Tianfu%22">Wen, Tianfu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Peng%2C+Wei%22">Peng, Wei</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<i> pengwei@wchscu.edu.cn</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Trials%22">Trials</searchLink>. 7/19/2024, Vol. 25 Issue 1, p1-9. 9p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=178528802 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13063-024-08340-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 9 StartPage: 1 Titles: – TitleFull: Neoadjuvant therapy of sequential TACE, camrelizumab, and apatinib for single huge hepatocellular carcinoma (NEO-START): study protocol for a randomized controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hao, Yun – PersonEntity: Name: NameFull: Xie, Fei – PersonEntity: Name: NameFull: Zhou, Yongjie – PersonEntity: Name: NameFull: Li, Chuan – PersonEntity: Name: NameFull: Zhang, Xiaoyun – PersonEntity: Name: NameFull: Shen, Junyi – PersonEntity: Name: NameFull: Yao, Minghong – PersonEntity: Name: NameFull: Sun, Xin – PersonEntity: Name: NameFull: Zhou, Jin – PersonEntity: Name: NameFull: Wen, Tianfu – PersonEntity: Name: NameFull: Peng, Wei IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 07 Text: 7/19/2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 17456215 Numbering: – Type: volume Value: 25 – Type: issue Value: 1 Titles: – TitleFull: Trials Type: main |
| ResultId | 1 |